Wearables for the Bladder: an In-home Treatment Feasibility Pilot Study (WeB)
Multiple Sclerosis, Urinary Bladder, Overactive
About this trial
This is an interventional treatment trial for Multiple Sclerosis focused on measuring multiple sclerosis, remote, wearables, overactive bladder, pelvic floor physical therapy
Eligibility Criteria
Inclusion Criteria: MS diagnosis Assigned Female at birth and whose sex is currently Female Mild/moderate bladder dysfunction (bowel/bladder functional systems scores = 0-2 or Bladder control scale >0) California residents Wifi in the home and personal smartphone (using Apple operating system) Able to walk with or without assistive device Manual muscle test score of 2 or more. Exclusion Criteria: Undergone treatment for bladder dysfunction symptoms within 3 months Current urinary tract infection Recent (~30 days) relapse Any cognitive, dexterity or visual impairment so severe that it precludes use of the wearables for the bladder tool or ability to use a smartphone Pregnancy
Sites / Locations
- University of California San Francisco, Weill Institute for NeurosciencesRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
WeB and pelvic floor physical therapy group
Control pelvic floor physical therapy group
This group will receive standard PFPT as well as WeB device for 12 weeks, and MS-symptom (including bladder bother) related questionnaires at baseline, 12 weeks and 6 months post intervention. Participants will also be provided with a remote activity monitor to use during the study.
This group will receive standard PFPT for 12 weeks. MS-symptom (including bladder bother) related questionnaires at baseline, 12 weeks and 6 months after the last PFPT visit. Patients will be invited to use WeB devices after this time.